Search clinical trials for: IL-2 receptor agonist
Total 83426 results
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity Cancer | Fallopian Tube AdenocarcinomaUnited States
-
The First Hospital of Jilin UniversityCompletedPurpura, Schoenlein-HenochChina
-
Leonard ApplemanPrometheus LaboratoriesCompletedMetastatic Renal Cell CarcinomaUnited States
-
Sheba Medical CenterUnknownMetastatic Ovarian CancerIsrael
-
St. Jude Children's Research HospitalCURE Childhood Cancer, Inc.Completed
-
Stanley H. Appel, MDUnknownALS (Amyotrophic Lateral Sclerosis)United States
-
Beijing YouAn HospitalUnknownHepatocellular CarcinomaChina
-
Masonic Cancer Center, University of MinnesotaCompletedStage IV MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedGraft-Versus-Host-DiseaseUnited States
-
Peking University People's HospitalTerminated
-
The Methodist Hospital Research InstituteGenentech, Inc.TerminatedSafety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney CancerCarcinoma, Renal CellUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH); Chiron...CompletedKidney CancerUnited States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Chiron CorporationCompletedKidney CancerUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...WithdrawnCHRONIC LYMPHOCYTIC B-LEUKEMIA
-
EndocyteTerminatedRenal Cell CarcinomaUnited States
-
Italian Trial in Medical OncologyCompletedRenal Cell Carcinoma | Metastatic DiseaseItaly
-
Mersin UniversityRecruiting
-
Neurogene Inc.Merck Sharp & Dohme LLCActive, not recruitingSolid Tumor | Advanced Solid TumorUnited States, Australia, Canada
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
Peking University People's HospitalUnknownMacrophage Activation SyndromeChina
-
Century Therapeutics, Inc.Not yet recruitingSystemic Lupus Erythematosus
-
University of Texas Southwestern Medical CenterPrometheus LaboratoriesCompletedMetastatic Clear Cell Renal Cell CarcinomaUnited States
-
University of ZurichSteno Diabetes Center CopenhagenCompletedType 2 DiabetesSwitzerland, Denmark
-
Anaveon AGTerminatedHematologic Diseases | Multiple Myeloma | Refractory Multiple Myeloma | Adult Disease | Relapsed CancerSpain, Germany, France, Denmark, Switzerland
-
Region SkaneLund UniversityRecruiting
-
Tel-Aviv Sourasky Medical CenterKU Leuven; Michael J. Fox Foundation for Parkinson's ResearchCompletedParkinson DiseaseIsrael, Belgium
-
Leiden University Medical CenterKarolinska Institutet; Children's Investment Fund Foundation; Women on WavesNot yet recruitingFemale ContraceptionNetherlands
-
Second Affiliated Hospital of Soochow UniversityRecruitingAdvanced Solid Tumor | Refractory TumorChina
-
Peking Union Medical College HospitalNot yet recruiting
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Century Therapeutics, Inc.RecruitingAggressive Non-Hodgkin Lymphoma | R/R CD19-Positive B-Cell Malignancies | Indolent Non-Hodgkin LymphomaUnited States
-
Second Affiliated Hospital of Soochow UniversityRecruitingAdvanced Refractory Solid TumorsChina
-
Megan Daly, MDMerck Sharp & Dohme LLCRecruitingMetastatic Renal Cell Carcinoma | Non Small Cell Lung Cancer | Metastatic Melanoma | Head and Neck Squamous Cell CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLC; Prometheus LaboratoriesActive, not recruiting
-
Columbia UniversityAmgenCompleted
-
Zhujiang HospitalShenzhen Geno-Immune Medical InstituteWithdrawnInterleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell MalignanciesB-Cell Leukemia | B-Cell LymphomaChina
-
The University of Texas Health Science Center,...Active, not recruitingHypertension in Pregnancy | Postpartum PreeclampsiaUnited States
-
Beth Israel Deaconess Medical CenterCompletedLiver TransplantationUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
The First Hospital of Jilin UniversityCompletedSystemic Lupus ErythematosusChina
-
Centre Hospitalier Universitaire de NīmesCompletedAmyotrophic Lateral SclerosisFrance, United Kingdom
-
National Institute of Allergy and Infectious Diseases...Chiron CorporationCompletedHIV InfectionsUnited States, Brazil, Australia, Argentina, Austria, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Japan, Morocco, Netherlands, Norway, Poland, Portugal, Singapore, Spain, Sweden, Switzerland, Thailand, United Kingdom
-
Oxford BioMedicaColumbia University; ORION Clinical ServicesCompletedA Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell CancerCarcinoma, Renal CellUnited States
-
Peking University People's HospitalUnknownAcute Graft-versus-host DiseaseChina
-
St. Anna KinderkrebsforschungCentre Leon Berard; Medical University of Graz; Fondazione IRCCS Istituto Nazionale... and other collaboratorsUnknownNeuroblastomaFrance, Spain, Austria, Germany, Israel, Italy, United Kingdom
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedGraft Versus Host DiseaseUnited States